secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2023-10-30T23:59:59+00:00
Accession:  0001493152-23-038620
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic closes 3rd tranche of unit financing, raising $1.05M via convertible notes and warrants
--------------------------------------------------------------------------------

- 42 units issued at $25,000 each for aggregate $1.05M; each unit includes a convertible note and 250,000 warrants.
- Notes convertible at $0.10/share; warrants exercisable at $0.12/share; placement agent fees of $157,500 paid.
- Debt of $1.05M from 27 accredited investors converted into the units under the subscription agreements.
- Third tranche of a financing previously reported in July 2023; total units subject to best-efforts placement agent agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/0001493152-23-038620-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315223038620/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038620

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer